» Articles » PMID: 9143577

Causes of Death and Recurrence After Surgery for Early Gastric Cancer

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 1997 May 1
PMID 9143577
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The postoperative course of 172 patients with early gastric cancer (EGC) was followed for a median 7 years to evaluate the causes of death, incidence and patterns of recurrence, and characteristic findings in the recurrent cases. The cumulative 10-year mortality rate (+/- SE) was 22 +/- 3.7%. Seven patients (4.1%) died of operative mortality, 11 (6.4%) died of a recurrence of the gastric cancer and 13 (7.6%) died of unrelated causes. Unrelated causes of death were metachronous primary cancer (n = 6), cardiovascular disease (n = 2), pneumonia (n = 3), sepsis (n = 1), and car accident (n = 1). Four patients died from gastric stump recurrence, three from liver metastases, two from lymph node metastases, and two from peritoneal dissemination. Using Cox multivariate analysis, histologic type had the most significant effect on recurrence. Although influenced by the tumor nature, the EGC prognosis is relatively good. Based on the results of this study, particularly in Western institutions, histologic examination of resection margins and lymphadenectomy should be improved. Moreover, patients must be carefully followed for late recurrence and metachronous cancer.

Citing Articles

Metastatic bone lesion type in gastric cancer patients: imaging findings of case reports.

Porta-Vilaro M, Soler-Perromat J, Larque A, Bartolome-Solanas A, Isern-Kebschull J, Garcia-Diez A Quant Imaging Med Surg. 2024; 14(11):7872-7880.

PMID: 39544462 PMC: 11558497. DOI: 10.21037/qims-24-425.


Two web-based dynamic prediction models for the diagnosis and prognosis of gastric cancer with bone metastases: evidence from the SEER database.

Liu B, Li K, Ma R, Zhang Q Front Endocrinol (Lausanne). 2023; 14:1136089.

PMID: 37293503 PMC: 10244808. DOI: 10.3389/fendo.2023.1136089.


Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer.

Sun P, Antwi S, Sartorius K, Zheng X, Li X Cancers (Basel). 2022; 14(19).

PMID: 36230816 PMC: 9563035. DOI: 10.3390/cancers14194888.


Advanced esophagogastric junction cancer with brain, bone and gastric intramural metastases responding to combined modality therapy.

Takagi T, Kobayashi S, Sekimura A, Komaya K, Yamauchi Y, Hori A J Rural Med. 2021; 16(3):179-183.

PMID: 34239632 PMC: 8249363. DOI: 10.2185/jrm.2020-055.


Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.

Petrillo A, Giunta E, Pappalardo A, Bosso D, Attademo L, Cardalesi C J Clin Med. 2021; 10(8).

PMID: 33921760 PMC: 8073984. DOI: 10.3390/jcm10081777.